Company’s tool supports clinicians and researchers working to visualize, analyze and understand the genome in a low-cost, high throughput platform
— Sheila Corcoran, evizia, Chief Operating Officer
RICHMOND, VIRGINIA, UNITED STATES, September 14, 2022 /EINPresswire.com/ — Virginia Venture Partners, the equity investment program of Virginia Innovation Partnership Corporation (VIPC), today announced an investment in Richmond, Va.-based Evizia. Evizia is building and deploying a breakthrough life science tool which enables high resolution visualization of the genome, assisting researchers working to understand and develop treatments for complex genetic disorders. This investment supports the design and manufacturing of the platform’s new generation and placement with research partners.
Evizia’s tool, PRECYSE, combines nanoimaging, nanoparticle chemistry and proprietary analytics to render quick, automated and accurate data. Its ability to flexibly measure specified regions quickly, accurately, and inexpensively unlocks assessments of sample quality as well identification of genomic variations that underly certain inherited diseases and cancers.
“At Evizia, we are committed to developing elegant, inexpensive, and effective tools enabling research scientists by resolving genomic complexity. Our team has a deep understanding of the industry, and we are on a mission to provide novel tools for cutting-edge researchers by addressing a significant pain point,” says Sheila Corcoran, Evizia COO and Co-Founder. “We are thrilled to be working alongside scientists and clinicians, developing applications for them. This investment by VIPC’s Virginia Venture Partners supports our growth and we are grateful for the investment.”
PRECYSE flexibly scans and measures DNA, meeting the needs of those who require fast and accurate characterization of genomic structures. The full product platform includes a desktop scanner, reagents and software applications thus automating analysis and delivering output in an easy-to-read format.
“The elucidation of certain structural variants can be a daunting task for genomics researchers,” said Alex Euler, Senior Investment Director, VIPC’s Virginia Venture Partners. “Evizia’s PRECYSE technology provides these researchers with a novel suite of tools that has the potential to revolutionize our understanding of the role that these structural variations play in certain cancers and rare diseases.”
Evizia is a start-up life science tools company providing clinicians and researchers with high resolution, automated genomic visualization and measurement. The platform was developed with wide-scale application and adoption in mind, embodied in a desktop scanner as well as companion reagents and software applications. To learn more about Evizia, visit https://eviziadx.com/.
About Virginia Venture Partners
Virginia Venture Partners, formerly CIT GAP Funds, is the equity investment program of VIPC that makes seed-stage equity investments in Virginia-based technology, clean energy, and life science companies with a high potential for achieving rapid growth and generating a significant economic return for entrepreneurs, co-investors, and the Commonwealth of Virginia. Since its inception in 2005, Virginia Venture Partners has deployed $32.4 million in capital across more than 250 portfolio companies, including 17 companies in designated Opportunity Zones. Virginia Venture Partners’ investment decisions are guided by the Virginia Venture Partners Investment Advisory Board (IAB). This independent, third-party panel has drawn from the expertise of leading regional entrepreneurs, angel, and strategic investors, and venture capital firms such as New Enterprise Associates, Grotech Ventures, Harbert Venture Partners HIG Ventures, Edison Ventures, In-Q-Tel, Intersouth Partners, SJF Ventures, Carilion Health Systems, Johnson & Johnson, General Electric, and Alpha Natural Resources. For more information, please visit www.virginiaipc.org/vvp.
About Virginia Innovation Partnership Corporation (VIPC)
Connecting innovators with opportunities. The nonprofit operations arm of the Virginia Innovation Partnership Authority (VIPA), VIPC is the commercialization and seed stage economic development driver in the Commonwealth that leads funding, infrastructure, and policy initiatives to support Virginia’s innovators, entrepreneurs, startups, and market development strategies. VIPC collaborates with local, regional, state, and federal partners to support the expansion and diversification of Virginia’s economy.
Programs include: Virginia Venture Partners (VVP) | Virginia Founders Fund (VFF) | Commonwealth Commercialization Fund (CCF) | Smart Communities | Unmanned Systems | Public Safety Innovation |Entrepreneurial Ecosystems | Regional Innovation Fund (RIF) | Federal Funding Assistance Program (FFAP) for SBIR & STTR | University Partnerships | Startup Company Mentoring & Engagement. For more information, please visit www.VirginiaIPC.org. Follow VIPC on Twitter, LinkedIn, and Facebook.
Angela Costello, Vice President of Communications
Virginia Innovation Partnership Corporation (VIPC)
Visit us on social media: